Answers are grounded in this paper and cite their sources.
Background Type 2 diabetes mellitus and tuberculosis frequently coexist in India. It is unclear whether glycated haemoglobin (HbA1c) measured at the time of tuberculosis diagnosis reflects the burden of diabetic complications and the severity of lung disease, or whether the acute infection distorts what a single HbA1c value means. We described the clinical, radiological and complication profile of patients with pulmonary tuberculosis and type 2 diabetes mellitus and compared these features by glycaemic control. Methods This cross-sectional study was conducted over 18 months in the Department of General Medicine of a tertiary teaching hospital in Western India. Forty-five adults with pulmonary tuberculosis and type 2 diabetes mellitus were enrolled consecutively and assessed clinically, biochemically and radiologically. Patients were stratified by HbA1c (< 9% or ≥ 9%) and compared using the independent-samples t-test and the chi-square or Fisher’s exact test; a p-value < 0.05 was considered significant. Results Mean age was 56.5 ± 12.5 years and 62.2% were male. Glycaemic control was poor overall (mean HbA1c 9.52 ± 1.40%). Diabetic retinopathy was present in 57.8%, albuminuria in 44.4% and peripheral neuropathy in 26.7% of patients, and 55.6% needed insulin intensification during tuberculosis treatment. Comparing HbA1c < 9% (n = 20) with ≥ 9% (n = 25), retinopathy (p = 0.55), neuropathy (p = 1.00) and radiological cavitation (p = 0.77) did not differ significantly. Insulin intensification was significantly more frequent with poorer control (84.0% vs 20.0%, p < 0.001). Unexpectedly, albuminuria was more common in the better-controlled group (70.0% vs 24.0%, p = 0.003), a group with significantly longer diabetes duration (9.2 ± 4.5 vs 6.2 ± 3.9 years, p = 0.019). Conclusions A single HbA1c at tuberculosis diagnosis tracked with insulin requirement but not with most microvascular complications or radiological severity, and was inversely related to albuminuria. This may reflect cumulative, duration-dependent renal injury and anaemia-related underestimation of glycaemic burden. In patients with both conditions, complication screening may need to be guided by diabetes duration rather than a single HbA1c value, and insulin-based glycaemic management should be anticipated during the acute infective illness. Trial registration: Not applicable.
No takes yet. Share an insight, caveat, or question.
Akay et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: